Myopi ve Progresyonu: Önleme ve Yönetim

Saw SM, Matsumura S, Hoang QV. Prevention and Management of Myopia and Myopic Pathology. Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):488-499. doi: 10.1167/iovs.18-25221. PMID: 30707221.

Murthy GV, Gupta SK, Ellwein LB, et al. Refractive error in children in an urban population in New Delhi. Invest Ophthalmol Vis Sci. 2002;43:623–631.

Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622-660.

Tedja MS, Haarman AEG, Meester-Smoor MA, et al. IMI—Genetics report. Invest Ophthalmol Vis Sci. 2019;60(3):M89-M105.

Jones LA, Sinnott LT, Mutti DO, et al. Parental history of myopia, sports and outdoor activities, and future myopia. Invest Ophthalmol Vis Sci. 2007;48(8):3524-3532.

Rose KA, Morgan IG, Ip J, et al. Outdoor activity reduces the prevalence of myopia in children. Ophthalmology. 2008;115(8):1279-1285.

Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet. 2012;379(9827):1739-1748.

Wu PC, Tsai CL, Wu HL, et al. Outdoor activity during class recess reduces myopia onset and progression in school children. Ophthalmology. 2013;120(5):1080-1085.

Rada JA, Shelton S, Norton TT. The sclera and myopia. Exp Eye Res. 2006;82(2):185-200.

Troilo D, Smith EL, Nickla DL, et al. IMI—Report on experimental models of emmetropization and myopia. Invest Ophthalmol Vis Sci. 2019;60(3):M31-M88.

Read SA, Alonso-Caneiro D, Vincent SJ, et al. Longitudinal changes in choroidal thickness and eye growth in childhood. Invest Ophthalmol Vis Sci. 2015;56(5):3103-3112.

Hu Y, Ding X, Guo X, et al. Association of age at myopia onset with risk of high myopia in adulthood in a 12-year follow-up of a Chinese cohort. JAMA Ophthalmol. 2020;138(11):1129-1136.

Brennan NA, Toubouti YM, Cheng X, et al. Efficacy in myopia control. Prog Retin Eye Res. 2021;83:100923.

Donovan L, Sankaridurg P, Ho A, et al. Myopia progression rates in urban children wearing single-vision spectacles. Optom Vis Sci. 2012;89(1):27-32.

Zadnik K, Sinnott LT, Cotter SA, et al. CLEERE Study Group. Prediction of juvenile-onset myopia. Invest Ophthalmol Vis Sci. 2015;56(6):3320-3325.

Gwiazda J, Hyman L, Hussein M, et al. COMET Study Group. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest Ophthalmol Vis Sci. 2003;44(4):1492-1500.

Vestergaard AH, Hjortdal JO, Ivarsen A,et al. Long-term outcomes of photorefractive keratectomy for low to high myopia: 13 to 19 years of follow-up. J Refract Surg. 2013;29:312–319.

Sugar A, Rapuano CJ, Culbertson WW, et al. Laser in situ keratomileusis for myopia and astigmatism: Safety and efficacy: A report by the American academy of ophthalmology. Ophthalmology. 2002;109:175–187.

Ashby R, Ohlendorf A, Schaeffel F. The effect of ambient illuminance on the development of deprivation myopia in chicks. Invest Ophthalmol Vis Sci. 2009;50:5348–5354.

He M, Xiang F, Zeng Y, et al. Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial. JAMA. 2015;314:1142– 1148

Read SA, Collins MJ, Vincent SJ. Light exposure and eye growth in childhood. Invest Ophthalmol Vis Sci. 2015;56:6779–6787

Chua WH, Balakrishnan V, Chan YH, et al. Atropine for the Treatment of Childhood Myopia. Ophthalmology. 2006;113(12):2285-2291. https://doi.org/10.1016/j.ophtha.2006.05.062 PMID: 17098186

Chia A, Lu QS, Tan D. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. Ophthalmology. 2016;123(2):391-399. https://doi.org/10.1016/j.ophtha.2015.07.004 PMID: 26271839

Yam JC, Jiang Y, Tang SM, et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology. 2019;126(1):91-101. https://doi.org/10.1016/j.ophtha.2018.05.029 PMID: 29908356

Bullimore MA, Sinnott LT, Jones-Jordan LA. The risk of microbial keratitis with overnight corneal reshaping lenses. Optom Vis Sci. 2013;90(9):937-944. https://doi.org/10.1097/OPX.0b013e31829da3d7

Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. Br J Ophthalmol. 2020;104(3):363-368. https://doi.org/10.1136/bjophthalmol-2018-313739